نتائج البحث - "Casper Nielsen"

1

دورية أكاديمية

Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT

المصدر: Efficacy and Mechanism Evaluation, Vol 8, Iss 19 (2021)

مصطلحات موضوعية: alzheimer’s disease, clinical trial, hypertension, renin–angiotensin system, vascular risk, losartan, mri, Medicine

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2050-4365Test; https://doaj.org/toc/2050-4373Test

الوصول الحر: https://doaj.org/article/81e153bea7a84db597fe5cde3dbfd1f0Test

View record in DOAJ

النص الكامل

2

Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial

المؤلفون: Patrick Gavin Kehoe, Nicholas Turner, Beth Howden, Lina Jarutyte, Shona Louise Clegg, Ian Brian Malone, Josephine Barnes, Casper Nielsen, Carole Hélène Sudre, Aileen Wilson, Ngoc Jade Thai, Peter Sinclair Blair, Elizabeth Coulthard, Janet Athene Lane, Peter Passmore, Jodi Taylor, Henk-Jan Mutsaerts, David Lee Thomas, Nick Charles Fox, Ian Wilkinson, Yoav Ben-Shlomo, Kirsty Harkness, Tarun Kuruvilla, Rupert McShane, Peter Connelly, Gordon Duncan, Lucy Calvert, Alasdair Lawrie, Matthew Sheridan, Eric Jackson, Bernard Udeze, Stephen Pearson, Tobias Langheinrich, Suvarna Wagle, Joseph Butchart, Ajay Macharouthu, Andrew Donaldson, Wendy Neil, Vivek Pattan, David Findlay, Alan Thomas, Robert Barber, Andrew Byrne, Madhusudan Dalvi, Rashi Negi, Bernadette McGuinness

المساهمون: Radiology and nuclear medicine, Neurology

المصدر: The Lancet. Neurology
Lancet Neurology, 20(11), 895-906. Lancet Publishing Group
Kehoe, P G, Turner, N, Howden, B, Jarutyte, L, Clegg, S L, Malone, I B, Barnes, J, Nielsen, C, Sudre, C H, Wilson, A, Thai, N J, Blair, P S, Coulthard, E, Lane, J A, Passmore, P, Taylor, J, Mutsaerts, H-J, Thomas, D L, Fox, N C, Wilkinson, I, Ben-Shlomo, Y & RADAR investigators 2021, ' Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial) : a double-blind, randomised, placebo-controlled, phase 2 trial ', Lancet Neurology, vol. 20, no. 11, pp. 895-906 . https://doi.org/10.1016/S1474-4422Test(21)00263-5
RADAR investigators 2021, ' Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial ', The Lancet. Neurology, vol. 20, no. 11, pp. 895-906 . https://doi.org/10.1016/S1474-4422Test(21)00263-5
2021, ' Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial) : a double-blind, randomised, placebo-controlled, phase 2 trial ', Lancet Neurology, vol. 20, no. 11, pp. 895-906 . https://doi.org/10.1016/S1474-4422Test(21)00263-5
Kehoe, P G, Turner, N, Howden, B, Jarutyte, L, Clegg, S L, Malone, I B, Barnes, J, Nielsen, C, Sudre, C H, Wilson, A, Thai, N J, Blair, P S, Coulthard, E, Lane, J A, Passmore, P, Taylor, J, Mutsaerts, H-J, Thomas, D L, Fox, N C, Wilkinson, I & Ben-Shlomo, Y 2021, ' Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial ', Lancet Neurology, vol. 20, no. 11, pp. 895-906 .

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4a28429bb9f725cd7e59ecafb894961Test
http://europepmc.org/articles/PMC8528717Test

3

دورية أكاديمية

Geographical Segmentation of U.S

المؤلفون: Rolf A. Heckemann A, Shiva Keihaninejad B, Paul Aljabar D, Katherine R. Gray D, Casper Nielsen C, Daniel Rueckert D, Joseph V. Hajnal E, Er Hammers A, Brain Pathology, Brain Atlas

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: http://www.doc.ic.ac.uk/%7Epa100/pubs/heckemannNeuroImage2011.pdfTest.

وصف الملف: application/pdf

العلاقة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.661.8394Test; http://www.doc.ic.ac.uk/%7Epa100/pubs/heckemannNeuroImage2011.pdfTest

الإتاحة: http://www.doc.ic.ac.uk/%7Epa100/pubs/heckemannNeuroImage2011.pdfTest

View record in BASE

4

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

المؤلفون: K Hunter, Dennis Chan, Richard Nicholas, Virginia L. Calder, Jennifer M. Nicholas, Nick C. Fox, Shona Clegg, Jeremy Chataway, Val Anderson, David Wilkie, John Greenwood, Chris Frost, David G. MacManus, Charles R. M. Bangham, A Alsanousi, Casper Nielsen, Nadine Schuerer

المساهمون: Chan, Dennis [0000-0002-4265-3718], Apollo - University of Cambridge Repository

المصدر: The Lancet. 383(9936):2213-2221

مصطلحات موضوعية: Male, Simvastatin, Administration, Oral, THERAPY, law.invention, DOUBLE-BLIND, Randomized controlled trial, law, AUTOIMMUNE-DISEASE, Medicine(all), Brain, General Medicine, Middle Aged, Multiple Sclerosis, Chronic Progressive, Cytokines, Female, Life Sciences & Biomedicine, CLINICAL-TRIALS, medicine.drug, INTERFERON, Adult, medicine.medical_specialty, Adolescent, Placebo, Young Adult, Atrophy, Medicine, General & Internal, VOLUME CHANGES, REDUCTASE INHIBITORS, Double-Blind Method, Internal medicine, General & Internal Medicine, medicine, Humans, Disabled Persons, NITRIC-OXIDE SYNTHASE, Adverse effect, Aged, Intention-to-treat analysis, Science & Technology, Dose-Response Relationship, Drug, business.industry, Multiple sclerosis, CENTRAL-NERVOUS-SYSTEM, OUTCOME MEASURE, medicine.disease, Clinical trial, Physical therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c655701f0a1f2e904a34c1420670e34aTest

5

Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease

المؤلفون: Gregg Keith M, Steven Einstein, Nick C. Fox, Enchi Liu, Iulia Cristina Tudor, Casper Nielsen, Bradley T. Wyman, Michael Grundman, H. Robert Brashear, Eric C. Yuen, Shona Clegg, Yuan Lu, Jianing Di, Gerald Novak, Peter C. Collins

المصدر: Journal of Alzheimer's disease : JAD. 49(4)

مصطلحات موضوعية: Apolipoprotein E, Male, medicine.medical_specialty, Pathology, Heterozygote, Dose, Apolipoprotein E4, Placebo, Antibodies, Monoclonal, Humanized, Gastroenterology, Severity of Illness Index, law.invention, Atrophy, Randomized controlled trial, Double-Blind Method, law, Alzheimer Disease, Internal medicine, medicine, Humans, Bapineuzumab, Least-Squares Analysis, Nootropic Agents, Aged, medicine.diagnostic_test, business.industry, General Neuroscience, Repeated measures design, Brain, Magnetic resonance imaging, General Medicine, Organ Size, medicine.disease, Magnetic Resonance Imaging, Psychiatry and Mental health, Clinical Psychology, Treatment Outcome, Female, Geriatrics and Gerontology, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92e2443c1059efa6cc108e569918fa56Test
https://pubmed.ncbi.nlm.nih.gov/26639957Test

6

Comparison of phantom and registration scaling corrections using the ADNI cohort

المؤلفون: Matthew J. Clarkson, Nick C. Fox, Michael W. Weiner, Sebastien Ourselin, Josephine Barnes, Jeffrey L. Gunter, Casper Nielsen, Clifford R. Jack, Derek L. G. Hill, Kelvin K. Leung, Jennifer L. Whitwell

المساهمون: Neurology, NCA - Neurodegeneration

المصدر: NeuroImage, 47(4), 1506-1513. Academic Press Inc.
Clarkson, M J, Ourselin, S, Nielsen, C, Leung, K K, Barnes, J, Whitwell, J L, Gunter, J L, Hill, D L G, Weiner, M W, Jack, C R & Fox, N C I 2009, ' Comparison of phantom and registration scaling corrections using the ADNI cohort ', NeuroImage, vol. 47, no. 4, pp. 1506-1513 . https://doi.org/10.1016/j.neuroimage.2009.05.045Test